• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

定量蛋白质组学鉴定 FOLR1 通过激活自噬来驱动肝癌细胞对索拉非尼的耐药性。

Quantitative proteomics identifies FOLR1 to drive sorafenib resistance via activating autophagy in hepatocellular carcinoma cells.

机构信息

Zhang Dayu School of Chemistry, Dalian University of Technology, Dalian, China.

CAS Key Laboratory of Separation Science for Analytical Chemistry, National Chromatographic R. & A. Center, Dalian Institute of Chemical Physics, Chinese Academy of Science, Dalian, China.

出版信息

Carcinogenesis. 2021 May 28;42(5):753-761. doi: 10.1093/carcin/bgab019.

DOI:10.1093/carcin/bgab019
PMID:33677528
Abstract

Sorafenib is commonly used to treat advanced human hepatocellular carcinoma (HCC). However, clinical efficacy has been limited by drug resistance. In this study, we used label-free quantitative proteomic analysis to systematically investigate the underlying mechanisms of sorafenib resistance in HCC cells. A total of 1709 proteins were confidently quantified. Among them, 89 were differentially expressed and highly enriched in the processes of cell-cell adhesion, negative regulation of apoptosis, response to drug and metabolic processes involving in sorafenib resistance. Notably, folate receptor α (FOLR1) was found to be significantly upregulated in resistant HCC cells. In addition, in vitro studies showed that overexpression of FOLR1 decreased the sensitivity of HCC cells to sorafenib, whereas siRNA-directed knockdown of FOLR1 increased the sensitivity of HCC cells to sorafenib. Immunoprecipitation-mass spectrometry analysis suggested a strong link between FOLR1 and autophagy-related proteins. Further biological experiments found that FOLR1-related sorafenib resistance was accompanied by the activation of autophagy, whereas inhibition of autophagy significantly reduced FOLR1-induced cell resistance. These results suggest the driving role of FOLR1 in HCC resistance to sorafenib, which may be exerted through FOLR1-induced autophagy. Therefore, this study may provide new insights into understanding the mechanism of sorafenib resistance.

摘要

索拉非尼通常用于治疗晚期人肝癌(HCC)。然而,临床疗效受到耐药性的限制。在这项研究中,我们使用无标记定量蛋白质组学分析系统地研究了 HCC 细胞中索拉非尼耐药的潜在机制。共定量了 1709 种蛋白质。其中,89 种在细胞间黏附、细胞凋亡的负调控、对药物的反应以及涉及索拉非尼耐药的代谢过程中差异表达且高度富集。值得注意的是,在耐药 HCC 细胞中发现叶酸受体α(FOLR1)显著上调。此外,体外研究表明,FOLR1 的过表达降低了 HCC 细胞对索拉非尼的敏感性,而 FOLR1 的 siRNA 介导的敲低增加了 HCC 细胞对索拉非尼的敏感性。免疫沉淀-质谱分析表明 FOLR1 与自噬相关蛋白之间存在很强的联系。进一步的生物学实验发现,FOLR1 相关的索拉非尼耐药伴随着自噬的激活,而自噬的抑制显著降低了 FOLR1 诱导的细胞耐药性。这些结果表明 FOLR1 在 HCC 对索拉非尼耐药中起驱动作用,可能是通过 FOLR1 诱导的自噬来发挥作用。因此,本研究可能为理解索拉非尼耐药机制提供新的见解。

相似文献

1
Quantitative proteomics identifies FOLR1 to drive sorafenib resistance via activating autophagy in hepatocellular carcinoma cells.定量蛋白质组学鉴定 FOLR1 通过激活自噬来驱动肝癌细胞对索拉非尼的耐药性。
Carcinogenesis. 2021 May 28;42(5):753-761. doi: 10.1093/carcin/bgab019.
2
LncRNA SNHG1 contributes to sorafenib resistance by activating the Akt pathway and is positively regulated by miR-21 in hepatocellular carcinoma cells.长链非编码 RNA SNHG1 通过激活 Akt 通路促进索拉非尼耐药,并且在肝癌细胞中受 miR-21 正向调控。
J Exp Clin Cancer Res. 2019 May 3;38(1):183. doi: 10.1186/s13046-019-1177-0.
3
MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway.微小RNA-21通过PTEN/蛋白激酶B信号通路抑制自噬,从而介导肝癌细胞对索拉非尼的耐药性。
Oncotarget. 2015 Oct 6;6(30):28867-81. doi: 10.18632/oncotarget.4814.
4
Inhibition of Akt reverses the acquired resistance to sorafenib by switching protective autophagy to autophagic cell death in hepatocellular carcinoma.抑制Akt可通过将保护性自噬转变为肝细胞癌中的自噬性细胞死亡来逆转对索拉非尼的获得性耐药。
Mol Cancer Ther. 2014 Jun;13(6):1589-98. doi: 10.1158/1535-7163.MCT-13-1043. Epub 2014 Apr 4.
5
Cancer-associated fibroblasts induce sorafenib resistance of hepatocellular carcinoma cells through CXCL12/FOLR1.肿瘤相关成纤维细胞通过 CXCL12/FOLR1 诱导肝癌细胞对索拉非尼产生耐药性。
BMC Cancer. 2023 Dec 6;23(1):1198. doi: 10.1186/s12885-023-11613-8.
6
Small interfering RNA targeting alpha7 nicotinic acetylcholine receptor sensitizes hepatocellular carcinoma cells to sorafenib.靶向α7 烟碱型乙酰胆碱受体的小干扰 RNA 增敏索拉非尼治疗肝癌细胞。
Life Sci. 2020 Mar 1;244:117332. doi: 10.1016/j.lfs.2020.117332. Epub 2020 Jan 18.
7
CD24 regulates sorafenib resistance via activating autophagy in hepatocellular carcinoma.CD24 通过激活肝细胞癌中的自噬来调节索拉非尼耐药性。
Cell Death Dis. 2018 May 29;9(6):646. doi: 10.1038/s41419-018-0681-z.
8
ID1-induced p16/IL6 axis activation contributes to the resistant of hepatocellular carcinoma cells to sorafenib.ID1 诱导的 p16/IL6 轴激活有助于肝癌细胞对索拉非尼的耐药性。
Cell Death Dis. 2018 Aug 28;9(9):852. doi: 10.1038/s41419-018-0926-x.
9
MiR-375 attenuates sorafenib resistance of hepatocellular carcinoma cells by inhibiting cell autophagy.miR-375 通过抑制细胞自噬来减弱肝癌细胞对索拉非尼的耐药性。
Acta Biochim Pol. 2023 Apr 17;70(2):239-246. doi: 10.18388/abp.2020_5657.
10
Increased expression of SLC46A3 to oppose the progression of hepatocellular carcinoma and its effect on sorafenib therapy.SLC46A3 的高表达可抑制肝细胞癌的进展及其对索拉非尼治疗的影响。
Biomed Pharmacother. 2019 Jun;114:108864. doi: 10.1016/j.biopha.2019.108864. Epub 2019 Apr 10.

引用本文的文献

1
PathSynergy: a deep learning model for predicting drug synergy in liver cancer.PathSynergy:一种用于预测肝癌药物协同作用的深度学习模型。
Brief Bioinform. 2025 Mar 4;26(2). doi: 10.1093/bib/bbaf192.
2
Phosphoproteomics profiling of sorafenib-resistant hepatocellular carcinoma patient-derived xenografts reveals potential therapeutic strategies.索拉非尼耐药的肝癌患者来源异种移植瘤的磷酸化蛋白质组学分析揭示了潜在的治疗策略。
iScience. 2024 Dec 20;28(1):111657. doi: 10.1016/j.isci.2024.111657. eCollection 2025 Jan 17.
3
Noncanonical function of folate through folate receptor 1 during neural tube formation.
叶酸通过叶酸受体 1 在神经管形成过程中的非典型功能。
Nat Commun. 2024 Feb 22;15(1):1642. doi: 10.1038/s41467-024-45775-1.
4
Cancer-associated fibroblasts induce sorafenib resistance of hepatocellular carcinoma cells through CXCL12/FOLR1.肿瘤相关成纤维细胞通过 CXCL12/FOLR1 诱导肝癌细胞对索拉非尼产生耐药性。
BMC Cancer. 2023 Dec 6;23(1):1198. doi: 10.1186/s12885-023-11613-8.
5
Autophagy plays a double-edged sword role in liver diseases.自噬在肝脏疾病中起着双刃剑的作用。
J Physiol Biochem. 2022 Feb;78(1):9-17. doi: 10.1007/s13105-021-00844-7. Epub 2021 Oct 18.